Authors
Helen H. Moon, MD
Latest:
Discussing the Role of Tivozanib in the Third-Line of RCC TreatmentWith updated data for the usefulness of tivozanib, patients with recurrent clear cell renal carcinoma have an effective option for treatment in a treatment landscape previously without many treatment options.
